Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tocagen
Biotech
Struggling Tocagen becomes Nasdaq on-ramp for Forte Bio
Out of options, Tocagen will become Forte Biosciences’ route to the public markets through an all-stock reverse merger.
Amirah Al Idrus
Feb 21, 2020 10:18am
After failed cancer test, Tocagen slashes staff
Oct 3, 2019 9:25am
Tocagen fails brain cancer test, shares crater
Sep 12, 2019 8:05am
Abeona fires CEO Carsten Thiel—Chutes & Ladders
Nov 30, 2018 9:30am
Lori Kunkel takes acting CMO role at Tocagen
Nov 16, 2018 9:26am
Curis moves up COO as CEO Fattaey departs—Chutes & Ladders
Sep 28, 2018 10:00am
